Dr. Vipan Dhall founded Credence Pharma Consulting to provide strategic and technical leadership for product development and portfolio selection. Dr. Dhall has taken increasing responsibilities in R&D and business operations over his 25+ years of experience. Dr. Dhall has been the CSO (Adare Pharmasolutions), Global R&D head with Piramal Healthcare, Canada, while managing R&D teams based in US, UK and India.  He has vast experience in development of Generics, Complex generics formulations (505B2s) and NCEs, having worked in companies like Dabur, Ranbaxy (now Sun Pharma), Dr. Reddys, Piramal, NPS Pharmaceuticals (now Shire) and Patheon.

Dr. Dhall brings demonstrated leadership experience with P&L responsibility having led teams in Formulations development, Drug discovery and Clinical BE US, UK and India. Over the years, he has been involved in development of over 100+ NCEs and Generics formulations, including Para IV generics. Of notable mention include, Ciprofloxacin Once-Daily controlled release (Cipro-OD), Tosymra Nasal Spray, Natpara (PTH injection), Gattex (Teduglutide injection), Cinacalcet Tablets and several other client projects. Vipan has been the inventor on 4 filed patents.

Vipan holds a Ph.D. and Master’s Degree in Pharmaceutical sciences. Vipan has an entrepreneurial approach to leveraging the potential of R&D and Pharma, CDMO and TICs organizations for maximizing value for internal and external shareholders for the benefit of patients at large.